|
|
|
|
 |
Edwards Lifesciences is a global leader in cardiovascular cannulae and advanced cardioplegia products, dedicated to partnering with surgeons and perfusionists to provide protection-based cannula solutions, ongoing education and product support in order to provide the best possible outcomes for patients during cardiac surgery.
Through its close work with clinicians, Edwards has led the development of advanced cannulae that enable many different cardiac surgery procedures and approaches. The products are designed with the needs of clinicians and the outcomes of patients in mind: arterial cannulae are designed for protection; venous cannulae facilitate high flow in small spaces; femoral cannulae provide increased options for safer insertion; and the cardioplegia products designed to maximize global myocardial protection. As part of Edwards’ commitment to clinicians, all are designed for ease-of-use.
In utilizing Edwards cannulae, the cardiac surgery team has access to quality products that focus on protecting patients, opportunities for education and support to stay on the cutting-edge of surgical techniques, and the chance to foster development of a U.S.-based manufacturing operation dedicated to advancing the field of cardiac surgery.
| Edwards arterial, venous, femoral and cardioplegia cannulae are manufactured in the United States. Edwards recently reinforced this commitment by developing a new state-of-the-art facility in Utah, which will enable significant expansion of both R&D and production capabilities. The company will retain more than 200 current jobs and, during the next 15 years, Edwards will add an estimated 1,000 new jobs in manufacturing, business and engineering at the new facility. | |  |
 |
|
|